-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On Sionna Therapeutics with Outperform Rating, Announces Price Target of $53

Benzinga·05/05/2026 13:24:31
Listen to the news
Wedbush analyst Laura Chico initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Outperform rating and announces Price Target of $53.